Skin Antiseptic Products Market Size, Share & Trends Analysis Report By Formulations (Alcohols), By Type (Solutions), By Application (Surgeries), By End-use (Hospitals), By Region, And Segment Forecasts, 2023 - 2032

The global skin antiseptic products market was valued at USD 6.5 billion in 2022 and is expected to impel at a CAGR of 7.3% by 2032.Demand for skin antiseptic products market is increasing due to the rising prevalence of hospital acquired diseases or hospital acquired infection (HAI) and increasing use of surgical units and endoscope reprocesses.

Key Pointers

• The highest revenue-generating segment with a market share of 48.4% in 2022.
• The wipes segment is anticipated to witness the fastest growth of CAGR of 7.1% over the forecast period.
• The injection segment dominated the skin antiseptic products market in 2022 with a market share of 72.2% and is anticipated to witness the fastest growth over the forecast period.
• The surgeries segment is anticipated to witness a significant growth rate of 5.5% over the forecast period.
• The hospital segment dominated the skin antiseptic products market in 2022 with a market share of 48.5%.
• The outpatient facilities segment is anticipated to witness a significant growth rate of 7.5% over the forecast period.
• Asia-Pacific is expected to witness the fastest growth rate of 7.4% over the forecast period.

Report Scope of the Skin Antiseptics Products Market:

Increasing cases of hospital-acquired infections due to lack of sanitation & precaution are among the major factors contributing to market growth. According to the Centers for Disease Control and Prevention (CDC), about 1 in 25 hospital patients has at least one healthcare-associated infection, on any given day. The use of antiseptics generally provides protection against contamination and lowers the risk of hospital-acquired infections. Moreover, it prevents bacteria, viruses, or other microbes that cause diseases from entering a patient’s body. Thus, such solutions are widely required in hospitals to maintain proper hygiene & sanitation, as well as to lower the risk of hospital-acquired infections. Therefore, this factor is expected to propel the market growth during the forecast period.

The growing rate of endoscopy is also expected to increase the risk of acquiring hospital-acquired infections. The most common types of infections that can occur after endoscopy include:

Gastrointestinal infections: This type of infection can occur if the endoscope is not properly cleaned and disinfected after and before use. The most common bacteria that cause gastrointestinal infections are Escherichia coli, Salmonella, and Clostridium difficile.

Respiratory infections: If the endoscope is not properly cleaned and disinfected, it can also transmit respiratory infections such as pneumonia or tuberculosis.

Urinary tract infections: If the endoscope is used to examine the urinary tract, there is a risk of transmitting urinary tract infections if the equipment is not properly cleaned and disinfected.

To prevent hospital-acquired infections due to endoscopy, hospitals, and medical facilities should follow strict protocols for cleaning and disinfecting the endoscopes and other equipment used during the procedure. Healthcare professionals should also adhere to strict hand hygiene practices and use appropriate antiseptic & disinfectant solutions to prevent the transmission of infections.

The COVID-19 pandemic has had a significant impact on the market for skin antiseptics, which are used to disinfect the skin before invasive procedures or surgery. With the increased emphasis on infection control and prevention during the pandemic, the demand for skin antiseptics has skyrocketed, leading to shortages and price increases. An increase in the number of vaccinations is leading to an increase in the use of injections

Moreover, to cope with the increasing demand, companies in the market are entering into strategic initiatives, such as product launches, geographical expansion, mergers, acquisitions, and partnerships. For instance, in February 2021, Avrio Health announced the launch of Betadine, Similarly, to increase its reach, Cardinal Health, announced the addition of a new distribution center in Columbus., Ohio. Thus, the above-mentioned factors are anticipated to propel the skin antiseptic product market during the post-pandemic period.

Skin Antiseptic Products Market Segmentation: